We designed our own in-house primers to validate the presence of this CYP19A1 variant in an independently-collected sample from the consultand, and to determine if a genotype-phenotype correlation might be made by tracking the variant through family members affected and unaffected by polycystic ovarian syndrome. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.